Latest Breaking News On - Carl daikeler - Page 1 : vimarsana.com

The Beachbody Company, Inc. (NYSE:BODY) Q1 2024 Earnings Call Transcript

The Beachbody Company, Inc. (NYSE:BODI) Q1 2024 Earnings Call Transcript

Beachbody Sees First Positive Free Cash Flow Since Going Public

By Karen Roman The Beachbody Company, Inc. (NYSE: BODI) said it had first positive free cash flow for the first time since going public– a sign that its turnaround plan is ahead of schedule. Free cash flow in the first quarter was $7.4 million compared with a loss of $11.3million in in the first quarter […]

BODi and Telehealth Provider Dr. B Partner to Enable Pre-Tax Reimbursement for BODi Fitness Solutions in all 50 States

BODi and Telehealth Provider Dr. B Partner to Enable Pre-Tax Reimbursement for BODi Fitness Solutions in all 50 States

The Beachbody Company, Inc. ("BODi"), a leading health and fitness company, announced today a strategic partnership with Dr. B, a leading telehealth provider that offers $15 online consultations for common conditions in all 50 states. The...

354 Sweat, Barriers, and the Birth of BODi: How Carl Daikeler Defined a New Fitness Category

On this episode of Christopher Lochhead: Follow your Different, we have a conversation with Carl Daikeler, the visionary CEO of BODi (formerly known as…

CEOs ask Wegovy's Novo Nordisk for advice after shift in trends

Novo Nordisk CEO reported getting calls from food executives about its highly coveted diabetes and weight loss drugs which continue to surge in demand

Shortage of Ozempic, other weight loss drugs creates pipeline for fake drugs

With certain diabetes and weight loss-related drugs in shortage, medical experts are raising alarms over growing concern for counterfeit versions.

Hear from BODi Exec Chairman Mark Goldston, CEO Carl Daikeler Live at ICR Conference

Exec Edge hosted a fireside chat at the 2024 ICR Conference with Executive Chairman Mark Goldston and Co-Founder & CEO Carl Daikeler of The Beachbody Co., Inc. or BODi (NYSE: BODY). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed the company’s cost saving initiatives and cash-based model, its key growth levers moving forward and […]

Experts express concern over pharmaceutical giant Eli Lilly's website connecting patients to obesity drugs

Eli Lilly, which makes obesity and diabetes drugs like Zepbound and Mounjaro, has launched a new website that connects patients to telehealth services, but the service worries some health experts.